Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8232886 | International Journal of Radiation Oncology*Biology*Physics | 2010 | 8 Pages |
Abstract
Retrospective implementation of fluorodeoxyglucose-PET for CTV specification for CT-guided brachytherapy for colorectal liver metastases revealed a significant change in the CTVs. Additional PET-positive tumor regions with incomplete dose coverage could explain unexpected early local progression.
Keywords
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Ingo G. M.D., Peter M.D., Ph.D., Ricarda M.D., Christian M.D., Dirk M.D., Lutz Ph.D., Wojciech M.D., Jens M.D., Holger M.D., Bernd M.D., Enrique Lopez M.D., Timm M.D.,